In der EU herrscht Impfstoff-Knappheit. Verfolgen Sie die Pressekonferenz mit der EU-Gesundheitskommissarin Stella Kyriakides jetzt hier im Livestream.
Archiv: Stella Kyriakides
With our Member States, we have requested from AZ a detailed planning of vaccine deliveries and when distribution will take place to Member States. Another meeting will be convened on Wednesday to discuss the matter further.
In addition, today we discussed with the 27 Member States in the Steering Board that an export transparency mechanism will be put in place as soon as possible. We want clarity on transactions and full transparency concerning the export of vaccines from the EU.
Press statement by Commissioner Kyriakides on vaccine deliveries and on the vaccine export transparency scheme
Good evening.
You know that AstraZeneca‘s vaccine is currently in the final stages of the approval process with the European Medicines Agency.
If all requirements are met, the European Medicines Agency could recommend market authorisation by the end of this week.
But there is a problem on the supply side.
Last Friday, the company AstraZeneca surprisingly informed the Commission and the European Union Member States that it intends to supply considerably fewer doses in the coming weeks than agreed and announced.
This new schedule is not acceptable to the European Union.
Coronavirus: EU locks horns with AstraZeneca on vaccine deliveries amid ‘supply shock’
n a sign of the EU’s frustration – after Pfizer also announced a temporary slowdown in vaccine supplies earlier in January – EU health commissioner Stella Kyriakides proposed forcing drug makers to register in advance their Covid-19 vaccine exports, so the bloc can keep track of what they are doing.
. @EU_Commission and Member States expressed deep dissatisfaction with this. We insisted on a precise delivery schedule on the basis of which Member States should be planning their vaccination programs, subject to the granting of a contitional marketing authorisation. /2
The @EU_Commission will continue to insist with @AstraZeneca on measures to increase predictability and stability of deliveries, and acceleration of the distribution of doses/3.
EU-Kommissarin verteidigt Impfstrategie
Gleichzeitig habe man mit anderen Herstellern Verträge geschlossen. „Wir waren uns in der EU einig, dass wir nicht alles auf eine Karte setzen dürfen“, so die Kommissarin. Sonst wären die EU-Staaten womöglich ohne wirksamen Impfstoff dagestanden.